Role of PPARγ in adipocyte recruitment and thermogenesis

References

• Davis TR, Johnston DR, Bell FC, Cremer BJ. Regulation of shivering and non-shivering heat production during acclimation of rats. Am. J. Physiol.198, 471–475 (1960).
   PubMed Web of Science ®Google Scholar
• Depocas F, Hart JS, Heroux O. Cold acclimation and the electromyogram of unanesthetized rats. J. Appl. Physiol.9(3), 404–408 (1956).
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim. Biophys. Acta1504(1), 82–106 (2001).
   PubMed Web of Science ®Google Scholar
• Cinti S. The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids73(1), 9–15 (2005).
   PubMed Web of Science ®Google Scholar
• Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J. Clin. Invest.102(2), 412–420 (1998).
   PubMed Web of Science ®Google Scholar
• Oberkofler H, Dallinger G, Liu YM, Hell E, Krempler F, Patsch W. Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans. J. Lipid Res.38(10), 2125–2133 (1997).
   PubMed Web of Science ®Google Scholar
• Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev.84(1), 277–359 (2004).
   PubMed Web of Science ®Google Scholar
• Huttunen P, Hirvonen J, Kinnula V. The occurrence of brown adipose tissue in outdoor workers. Eur. J. Appl. Physiol. Occup. Physiol.46(4), 339–345 (1981).
   PubMed Web of Science ®Google Scholar
• Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue in patients with phaeochromocytoma. Int. J. Obes.10(3), 219–227 (1986).
   PubMed Web of Science ®Google Scholar
• Fisher MH, Amend AM, Bach TJ et al. A selective human β3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J. Clin. Invest.101(11), 2387–2393 (1998).
   PubMed Web of Science ®Google Scholar
• Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring)14(Suppl. 5), S242–S249 (2006).
   PubMed Web of Science ®Google Scholar
• Klaus S, Casteilla L, Bouillaud F, Ricquier D. The uncoupling protein UCP: a membraneous mitochondrial ion carrier exclusively expressed in brown adipose tissue. Int. J. Biochem.23(9), 791–801 (1991).
   PubMedGoogle Scholar
• Ricquier D, Casteilla L, Bouillaud F. Molecular studies of the uncoupling protein. FASEB J.5(9), 2237–2242 (1991).
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Miller DS. Energy balance following sympathetic denervation of brown adipose tissue. Can. J. Physiol. Pharmacol.62(2), 235–240 (1984).
   PubMed Web of Science ®Google Scholar
• Hamann A, Flier JS, Lowell BB. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology137(1), 21–29 (1996).
   PubMed Web of Science ®Google Scholar
• Lowell BB, Susulic V, Hamann A et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature366(6457), 740–742 (1993).
   PubMed Web of Science ®Google Scholar
• Melnyk A, Harper ME, Himms-Hagen J. Raising at thermoneutrality prevents obesity and hyperphagia in BAT-ablated transgenic mice. Am. J. Physiol.272(4 Pt 2), R1088–R1093 (1997).
   PubMed Web of Science ®Google Scholar
• Kopecky J, Hodny Z, Rossmeisl M, Syrovy I, Kozak LP. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am. J. Physiol.270(5 Pt 1), E768–E775 (1996).
   PubMedGoogle Scholar
• Kopecky J, Clarke G, Enerback S, Spiegelman B, Kozak LP. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J. Clin. Invest.96(6), 2914–2923 (1995).
   PubMed Web of Science ®Google Scholar
• Stefl B, Janovska A, Hodny Z et al. Brown fat is essential for cold-induced thermogenesis but not for obesity resistance in aP2-Ucp mice. Am. J. Physiol.274(3 Pt 1), E527–E533 (1998).
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G, Vidal-Puig A. Gateway to the metabolic syndrome. Nat. Med.11(6), 602–603 (2005).
   PubMed Web of Science ®Google Scholar
• Lelliott C, Vidal-Puig AJ. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int. J. Obes. Relat. Metab. Disord.28(Suppl. 4), S22–S28 (2004).
   Web of Science ®Google Scholar
• Garg A. Lipodystrophies. Am. J. Med.108(2), 143–152 (2000).
   PubMed Web of Science ®Google Scholar
• Unger RH. Lipotoxic diseases. Annu. Rev. Med.53, 319–336 (2002).
   PubMed Web of Science ®Google Scholar
• Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int. J. Obes. Relat. Metab. Disord.24(Suppl. 4), S28–S32 (2000).
   PubMed Web of Science ®Google Scholar
• Bays H. Adiposopathy: role of adipocyte factors in a new paradigm. Expert Rev. Cardiovasc. Ther.3(2), 187–189 (2005).
   PubMedGoogle Scholar
• Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia43(12), 1498–1506 (2000).
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mangalat D, Korbut R. Adipocytokines – novel link between inflammation and vascular function? J. Physiol. Pharmacol.57(4), 505–528 (2006).
   PubMed Web of Science ®Google Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature444(7121), 875–880 (2006).
   PubMed Web of Science ®Google Scholar
• Gray SL, Nora ED, Grosse J et al. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor-γ function (P465L PPARγ) in mice. Diabetes55(10), 2669–2677 (2006).
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G, Virtue S, Lelliott C et al. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-γ2 isoform. Diabetes54(6), 1706–1716 (2005).
   PubMed Web of Science ®Google Scholar
• Sakai T, Sakaue H, Nakamura T et al. Skp2 controls adipocyte proliferation during the development of obesity. J. Biol. Chem.282(3), 2038–2046 (2007).
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Thummel C, Beato M et al. The nuclear receptor superfamily: the second decade. Cell83(6), 835–839 (1995).
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev.20(5), 649–688 (1999).
   PubMed Web of Science ®Google Scholar
• Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology137(1), 354–366 (1996).
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Davies PJ, Crombie DL et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature386(6623), 407–410 (1997).
   PubMed Web of Science ®Google Scholar
• Xu HE, Stanley TB, Montana VG et al. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature415(6873), 813–817 (2002).
   PubMed Web of Science ®Google Scholar
• McKenna NJ, O’Malley BW. Minireview: nuclear receptor coactivators – an update. Endocrinology143(7), 2461–2465 (2002).
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Heinrich R. Biological control through regulated transcriptional coactivators. Cell119(2), 157–167 (2004).
   PubMed Web of Science ®Google Scholar
• Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science274(5295), 2100–2103 (1996).
   PubMed Web of Science ®Google Scholar
• Pascual G, Fong AL, Ogawa S et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature437(7059), 759–763 (2005).
   PubMed Web of Science ®Google Scholar
• Ide T, Egan K, Bell-Parikh LC, FitzGerald GA. Activation of nuclear receptors by prostaglandins. Thromb. Res.110(5–6), 311–315 (2003).
   PubMed Web of Science ®Google Scholar
• Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA. Biosynthesis of 15-deoxy-δ12,14-PGJ2 and the ligation of PPARγ. J. Clin. Invest.112(6), 945–955 (2003).
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ (PPARγ). J. Biol. Chem.270(22), 12953–12956 (1995).
   PubMed Web of Science ®Google Scholar
• Kletzien RF, Clarke SD, Ulrich RG. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol. Pharmacol.41(2), 393–398 (1992).
   PubMed Web of Science ®Google Scholar
• Rangwala SM, Lazar MA. Transcriptional control of adipogenesis. Annu. Rev. Nutr.20, 535–559 (2000).
   PubMed Web of Science ®Google Scholar
• Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc. Natl Acad. Sci. USA92(21), 9856–9860 (1995).
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell79(7), 1147–1156 (1994).
   PubMed Web of Science ®Google Scholar
• Rosen ED, Sarraf P, Troy AE et al. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell4(4), 611–617 (1999).
   PubMed Web of Science ®Google Scholar
• Barak Y, Nelson MC, Ong ES et al. PPARγ is required for placental, cardiac, and adipose tissue development. Mol. Cell4(4), 585–595 (1999).
   PubMed Web of Science ®Google Scholar
• Masugi J, Tamori Y, Kasuga M. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARγ2 in 3T3-L1 cells. Biochem. Biophys. Res. Commun.264(1), 93–99 (1999).
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPARγ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev.8(10), 1224–1234 (1994).
   PubMed Web of Science ®Google Scholar
• Semple RK, Chatterjee VK, O’Rahilly S. PPARγ and human metabolic disease. J. Clin. Invest.116(3), 581–589 (2006).
   PubMed Web of Science ®Google Scholar
• Savage DB, Tan GD, Acerini CL et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γ. Diabetes52(4), 910–917 (2003).
   PubMed Web of Science ®Google Scholar
• Shadid S, Jensen MD. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care26(11), 3148–3152 (2003).
   PubMed Web of Science ®Google Scholar
• Tsai YS, Maeda N. PPARγ: a critical determinant of body fat distribution in humans and mice. Trends Cardiovasc. Med.15(3), 81–85 (2005).
   PubMed Web of Science ®Google Scholar
• Laplante M, Festuccia WT, Soucy G et al. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor-γ action on adipose tissue metabolism. Diabetes55(10), 2771–2778 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang J, Fu M, Cui T et al. Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity. Proc. Natl Acad. Sci. USA101(29), 10703–10708 (2004).
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G, Gray SL, Yetukuri L et al. PPARγ2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet.3(4), E64 (2007).
   PubMed Web of Science ®Google Scholar
• Foellmi-Adams LA, Wyse BM, Herron D, Nedergaard J, Kletzien RF. Induction of uncoupling protein in brown adipose tissue. Synergy between norepinephrine and pioglitazone, an insulin-sensitizing agent. Biochem. Pharmacol.52(5), 693–701 (1996).
   PubMed Web of Science ®Google Scholar
• Berthiaume M, Sell H, Lalonde J et al. Actions of PPARγ agonism on adipose tissue remodeling, insulin sensitivity, and lipemia in absence of glucocorticoids. Am. J. Physiol. Regul. Integr. Comp. Physiol.287(5), R1116–R1123 (2004).
   Google Scholar
• Fukui Y, Masui S, Osada S, Umesono K, Motojima K. A new thiazolidinedione, NC-2100, which is a weak PPARγ activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes49(5), 759–767 (2000).
   PubMed Web of Science ®Google Scholar
• Tan GD, Debard C, Tiraby C et al. A “futile cycle” induced by thiazolidinediones in human adipose tissue? Nat. Med.9(7), 811–812 (2003).
   PubMed Web of Science ®Google Scholar
• Tiraby C, Tavernier G, Lefort C et al. Acquirement of brown fat cell features by human white adipocytes. J. Biol. Chem.278(35), 33370–33376 (2003).
   PubMed Web of Science ®Google Scholar
• Imai T, Takakuwa R, Marchand S et al. Peroxisome proliferator-activated receptor-γ is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl Acad. Sci. USA101(13), 4543–4547 (2004).
   PubMed Web of Science ®Google Scholar
• Gray SL, Dalla NE, Backlund EC et al. Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARγ) function. Endocrinology147(12), 5708–5714 (2006).
   PubMed Web of Science ®Google Scholar
• Linhart HG, Ishimura-Oka K, DeMayo F et al. C/EBPα is required for differentiation of white, but not brown, adipose tissue. Proc. Natl Acad. Sci. USA98(22), 12532–12537 (2001).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J.16(24), 7432–7443 (1997).
   PubMed Web of Science ®Google Scholar
• Hansen JB, Kristiansen K. Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem. J.398(2), 153–168 (2006).
   PubMed Web of Science ®Google Scholar
• Hansen JB, Jorgensen C, Petersen RK et al. Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc. Natl Acad. Sci. USA101(12), 4112–4117 (2004).
   PubMed Web of Science ®Google Scholar
• Scime A, Grenier G, Huh MS et al. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1α. Cell Metab.2(5), 283–295 (2005).
   PubMed Web of Science ®Google Scholar
• Picard F, Gehin M, Annicotte J et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell111(7), 931–941 (2002).
   PubMed Web of Science ®Google Scholar
• Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell92(6), 829–839 (1998).
   PubMed Web of Science ®Google Scholar
• Lin J, Wu PH, Tarr PT et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell119(1), 121–135 (2004).
   PubMed Web of Science ®Google Scholar
• Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor-γ coactivator 1β (PGC-1β ), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem.277(3), 1645–1648 (2002).
   PubMed Web of Science ®Google Scholar
• Meirhaeghe A, Crowley V, Lenaghan C et al. Characterization of the human, mouse and rat PGC1β (peroxisome-proliferator-activated receptor-γ co-activator 1β) gene in vitro and in vivo. Biochem. J.373(Pt 1), 155–165 (2003).
   PubMed Web of Science ®Google Scholar
• Lin J, Tarr PT, Yang R et al. PGC-1β in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem.278(33), 30843–30848 (2003).
   PubMed Web of Science ®Google Scholar
• St-Pierre J, Lin J, Krauss S et al. Bioenergetic analysis of peroxisome proliferator-activated receptor-γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J. Biol. Chem.278(29), 26597–26603 (2003).
   PubMed Web of Science ®Google Scholar
• Kamei Y, Ohizumi H, Fujitani Y et al. PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl Acad. Sci. USA100(21), 12378–12383 (2003).
   PubMed Web of Science ®Google Scholar
• Lelliott CJ, Medina-Gomez G, Petrovic N et al. Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol.4(11), E369 (2006).
   PubMedGoogle Scholar
• Seydoux J, Girardier L. Control of brown fat thermogenesis by the sympathetic nervous system. Experientia32(Suppl.), 153–167 (1978).
   PubMedGoogle Scholar
• Kozak UC, Kopecky J, Teisinger J, Enerback S, Boyer B, Kozak LP. An upstream enhancer regulating brown-fat-specific expression of the mitochondrial uncoupling protein gene. Mol. Cell. Biol.14(1), 59–67 (1994).
   PubMed Web of Science ®Google Scholar
• Yubero P, Manchado C, Cassard-Doulcier AM et al. CCAAT/enhancer binding proteins α and β are transcriptional activators of the brown fat uncoupling protein gene promoter. Biochem. Biophys. Res. Commun.198(2), 653–659 (1994).
   PubMed Web of Science ®Google Scholar
• Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol. Rev.86(2), 435–464 (2006).
   PubMed Web of Science ®Google Scholar
• Digby JE, Montague CT, Sewter CP et al. Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes47(1), 138–141 (1998).
   PubMed Web of Science ®Google Scholar
• Sears IB, MacGinnitie MA, Kovacs LG, Graves RA. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor-γ. Mol. Cell. Biol.16(7), 3410–3419 (1996).
   PubMed Web of Science ®Google Scholar
• Thurlby PL, Wilson S, Arch JR. Ciglitazone is not itself thermogenic but increases the potential for thermogenesis in lean mice. Biosci. Rep.7(7), 573–577 (1987).
   PubMed Web of Science ®Google Scholar
• Sell H, Berger JP, Samson P et al. Peroxisome proliferator-activated receptor-γ agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinology145(8), 3925–3934 (2004).
   PubMed Web of Science ®Google Scholar
• Lindgren EM, Nielsen R, Petrovic N et al. Noradrenaline represses PPAR (peroxisome-proliferator-activated receptor)γ2 gene expression in brown adipocytes: intracellular signalling and effects on PPARγ2 and PPARγ1 protein levels. Biochem. J.382(Pt 2), 597–606 (2004).
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, Cannon B. PPARγ in the control of brown adipocyte differentiation. Biochim. Biophys. Acta1740(2), 293–304 (2005).
   PubMed Web of Science ®Google Scholar
• Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab.293(2), E444–E452 (2007).
   PubMed Web of Science ®Google Scholar
• Klaus S. Functional differentiation of white and brown adipocytes. Bioessays19(3), 215–223 (1997).
   PubMed Web of Science ®Google Scholar
• Loncar D, Bedrica L, Mayer J et al. The effect of intermittent cold treatment on the adipose tissue of the cat. Apparent transformation from white to brown adipose tissue. J. Ultrastruct. Mol. Struct. Res.97(1–3), 119–129 (1986).
   PubMedGoogle Scholar
• Champigny O, Ricquier D, Blondel O, Mayers RM, Briscoe MG, Holloway BR. β3-adrenergic receptor stimulation restores message and expression of brown-fat mitochondrial uncoupling protein in adult dogs. Proc. Natl Acad. Sci. USA88(23), 10774–10777 (1991).
   PubMed Web of Science ®Google Scholar
• Cinti S. Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J. Endocrinol. Invest.25(10), 823–835 (2002).
   PubMed Web of Science ®Google Scholar
• Cousin B, Cinti S, Morroni M et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell. Sci.103(Pt 4), 931–942 (1992).
   PubMed Web of Science ®Google Scholar
• Himms-Hagen J, Melnyk A, Zingaretti MC, Ceresi E, Barbatelli G, Cinti S. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am. J. Physiol. Cell Physiol.279(3), C670–C681 (2000).
   PubMed Web of Science ®Google Scholar
• Acheson KJ, Ravussin E, Schoeller DA et al. Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure. Metabolism37(1), 91–98 (1988).
   PubMed Web of Science ®Google Scholar
• Ravussin E, Lillioja S, Knowler WC et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N. Engl. J. Med.318(8), 467–472 (1988).
   PubMed Web of Science ®Google Scholar
• Tsukiyama-Kohara K, Poulin F, Kohara M et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat. Med.7(10), 1128–1132 (2001).
   PubMed Web of Science ®Google Scholar
• Cederberg A, Gronning LM, Ahren B, Tasken K, Carlsson P, Enerback S. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell106(5), 563–573 (2001).
   PubMed Web of Science ®Google Scholar
• Yang X, Enerback S, Smith U. Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes. Res.11(10), 1182–1191 (2003).
   PubMedGoogle Scholar
• Russell LK, Mansfield CM, Lehman JJ et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor-γ coactivator-1α promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ. Res.94(4), 525–533 (2004).
   PubMed Web of Science ®Google Scholar
• Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor-γ coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest.106(7), 847–856 (2000).
   PubMed Web of Science ®Google Scholar